Preloader
Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.


Report ID : IR100392 | Industries : Healthcare | Published On :May 2024 | Page Count : 248

  • Request Sample      Ask for Customization     Inquire Before Buying     Speak to Analyst



  • Global Vagus Nerve Stimulator Market Size, Trends & Growth Opportunity, By Product Type (Implantable VNS Devices, and External VNS Devices), By Biomaterial (Ceramics, Metallic, and Polymerics), By Application (Depression, Epilepsy, and Migraine), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
    Global Vagus Nerve Stimulator Market
    Global Vagus Nerve Stimulator Market was valued at USD 555.2 million in 2021 and is expected to reach USD 1195.9 million by 2027, at a CAGR 12.15% from 2022-2027.
    Vagus nerve Stimulator (VNS) is a medical treatment which involves delivering electrical impulses to the vagus nerve. It uses an implanted device to send an electrical pulse to one’s vagus nerve, which then travels to one’s brain. Vagus nerve stimulators are also called vagus nerve stimulation. Surgeons implant a device near the collarbone and run a wire to the vagus nerve. When the device fires it stimulates that nerve to send signals to the brain. This increases activity in areas that control mood. 
    Market Drivers
    Rising prevalence of neurological disorders is the key driving factor which is expected to drive the global vagus nerve stimulator market growth. Also, increase in investments in pharmaceutical and biotechnology industries and research and development activities will have a positive impact on market growth. 
    Moreover, growing technological advancements and increase in prevalence of neurological disorders such as epilepsy, depression, anxiety, and others is expected to boost growth of the global vagus nerve stimulators market over the forecast period 2027.
    Market Restraints
    The lack of skilled professionals is the major challenging factor which is expected to obstruct the global vagus nerve stimulator market growth. High costs associated with neurostimulator devices are also expected to hinder the market growth.
    Market Segmentation
    The Global Vagus Nerve Stimulator Market is segmented into product, biomaterial, application, end user, and region.
    Based on biomaterial, the Vagus Nerve Stimulator market is segmented into polymeric, metallic, and ceramic biomaterials. The polymeric segment is expected to advance at the highest growth rate of 2022 to 2037, owing to its flexibility benefits.
    Regional Analysis
    Global Vagus Nerve Stimulator Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
    The North American region dominates the vagus nerve stimulation market, owing to the growing government funding and initiatives for raising awareness about epilepsy and difficult-to-treat depression in the region. Also, rapid technological advancements, key manufacturers in the region, are among the key factors expected to create significant growth opportunities in the North American market.
    Key Players
    Various key players are discussed into the Global Vagus Nerve Stimulator Market Report including: Medtronic Plc, Nevro Corporation, EnteroMedics Inc, Bioness Inc, BioControl Medical, Aleva Neurotherapeutics SA, Boston Scientific Corporation, LivaNova Plc, ElectroCore LLC, and NeuroPace Inc.
    For instance, in March 2020, LivaNova had received the CE Mark approval for their VNS Therapy System - Symmetry - for difficult-to-treat depression. Such key players operating in the industry are increasingly focusing on technological advancements, product launches, and other growth strategies, such as mergers & acquisitions, to strengthen their foothold in the market.
    Market Taxonomy
    By Product Type

    •        Implantable VNS Devices
    •        External VNS Devices
    By Biomaterial
    •        Ceramics
    •        Metallic
    •        Polymerics
    By Application
    •        Depression
    •        Epilepsy
    •        Migraine
    By End User
    •        Hospitals
    •        Ambulatory Surgical Centres
    •        Others
    By Region
    •        North America
    •        Latin America
    •        Europe
    •        Asia Pacific
    •        Middle East & Africa

    Global Vagus Nerve Stimulator Market TOC:
    1 Introduction 
    1.1 Objective of the Study
    1.2 Market definition
    1.3 Market Scope
    2 Research Methodology
    2.1 Data Mining
    2.2 Validation
    2.3 Primary Interviews
    2.4 List of Data Sources
    3 Executive Summary
    4 Global Vagus Nerve Stimulator Market Outlook
    4.1 Overview
    4.2 Market Dynamics
    4.2.1 Drivers
    4.2.2 Restraints
    4.2.3 Opportunities
    4.3 Porters Five Force Model
    4.4 Value Chain Analysis
    5 Global Vagus Nerve Stimulator Market, By Product Type
    5.1 Y-o-Y Growth Comparison, By Product Type 
    5.2 Global Vagus Nerve Stimulator Market Share Analysis, By Product Type 
    5.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Product Type
    5.3.1 Implantable VNS Devices
    5.3.2 External VNS Devices
    6 Global Vagus Nerve Stimulator Market, By Biomaterial
    6.1 Y-o-Y Growth Comparison, By Biomaterial
    6.2 Global Vagus Nerve Stimulator Market Share Analysis, By Biomaterial
    6.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
    6.3.1 Ceramics
    6.3.2 Reusable
    6.3.3 Polymerics
    7 Global Vagus Nerve Stimulator Market, By Application
    7.1 Y-o-Y Growth Comparison, By Application
    7.2 Global Vagus Nerve Stimulator Market Share Analysis, By Application
    7.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Application
    7.3.1 Depression
    7.3.2 Epilepsy
    7.3.3 Margarine 
    8 Global Vagus Nerve Stimulator Market, By End User
    8.1 Y-o-Y Growth Comparison, By End User
    8.2 Global Vagus Nerve Stimulator Market Share Analysis, By End User
    8.3 Global Vagus Nerve Stimulator Market Size and Forecast, By End User
    8.3.1 Hospitals
    8.3.2 Ambulatory Surgical Center
    8.3.3 Others
    9 Global Vagus Nerve Stimulator Market, By Region
    9.1 Global Vagus Nerve Stimulator Market Share Analysis, By Region
    9.2 Global Vagus Nerve Stimulator Market Share Analysis, By Region
    9.3 Global Vagus Nerve Stimulator Market Size and Forecast, By Region
    10 North America Vagus Nerve Stimulator Analysis and Forecast (2022 – 2027)
    10.1 Introduction
    10.2 North America Vagus Nerve Stimulator Market Share Analysis, By Product Type
    10.3 North America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial
    10.4 North America Vagus Nerve Stimulator Market Size and Forecast, By Application
    10.5 North America Vagus Nerve Stimulator Market Size and Forecast, By End User
    10.6 North America Vagus Nerve Stimulator Market Size and Forecast, By Country
    10.6.1 U.S.
    10.6.2 Canada
    10.6.3 Mexico
    11 Europe Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
    11.1 Introduction
    11.2 Europe Vagus Nerve Stimulator Market Share Analysis, By Product Type 
    11.3 Europe Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial 
    11.4 Europe Vagus Nerve Stimulator Market Size and Forecast, By Application
    11.5 Europe Vagus Nerve Stimulator Market Size and Forecast, By End User
    11.6 Europe Vagus Nerve Stimulator Market Size and Forecast, By Country
    11.6.1 Germany
    11.6.2 France
    11.6.3 UK
    11.6.4 Rest of Europe
    12 Asia Pacific Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
    12.1 Introduction
    12.2 Asia Pacific Vagus Nerve Stimulator Market Share Analysis, By Product Type 
    12.3 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial  
    12.4 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Application
    12.5 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By End User
    12.6 Asia Pacific Vagus Nerve Stimulator Market Size and Forecast, By Country
    12.6.1 China
    12.6.2 Japan
    12.6.3 India
    12.6.4 Rest of Asia Pacific
    13 Latin America Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
    13.1 Introduction
    13.2 Latin America Vagus Nerve Stimulator Market Share Analysis, By Product Type 
    13.3 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial 
    13.4 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Application
    13.5 Latin America Vagus Nerve Stimulator Market Size and Forecast, By End User
    13.6 Latin America Vagus Nerve Stimulator Market Size and Forecast, By Country
    13.6.1 Brazil
    13.6.2 Rest of Latin America
    14 Middle East Vagus Nerve Stimulator Market Analysis and Forecast (2022 – 2027)
    14.1 Introduction
    14.2 Middle East Vagus Nerve Stimulator Market Share Analysis, By Product Type 
    14.3 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Biomaterial 
    14.4 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Application
    14.5 Middle East Vagus Nerve Stimulator Market Size and Forecast, By End User
    14.6 Middle East Vagus Nerve Stimulator Market Size and Forecast, By Country
    14.6.1 Saudi Arabia
    14.6.2 UAE
    14.6.3 Egypt
    14.6.4 Kuwait
    14.6.5 South Africa
    15 Competitive Analysis
    15.1 Competition Dashboard
    15.2 Market share Analysis of Top Vendors
    15.3 Key Development Strategies
    16 Company Profiles
    16.1 Medtronic Plc
    16.1.1 Overview
    16.1.2 Offerings
    16.1.3 Key Financials
    16.1.4 Business Segment & Geographic Overview
    16.1.5 Key Market Developments
    16.1.6 Key Strategies
    16.2 Nevro Corporation
    16.2.1 Overview
    16.2.2 Offerings
    16.2.3 Key Financials
    16.2.4 Business Segment & Geographic Overview
    16.2.5 Key Market Developments
    16.2.6 Key Strategies
    16.3 EnteroMedics Inc.
    16.3.1 Overview
    16.3.2 Offerings
    16.3.3 Key Financials
    16.3.4 Business Segment & Geographic Overview
    16.3.5 Key Market Developments
    16.3.6 Key Strategies
    16.4 Bioness Inc.
    16.4.1 Overview
    16.4.2 Offerings
    16.4.3 Key Financials
    16.4.4 Business Segment & Geographic Overview
    16.4.5 Key Market Developments
    16.4.6 Key Strategies
    16.5 BioControl Medical
    16.5.1 Overview
    16.5.2 Offerings
    16.5.3 Key Financials
    16.5.4 Business Segment & Geographic Overview
    16.5.5 Key Market Developments
    16.5.6 Key Strategies
    16.6 Aleva Neurotherapeutics SA
    16.6.1 Overview
    16.6.2 Offerings
    16.6.3 Key Financials
    16.6.4 Business Segment & Geographic Overview
    16.6.5 Key Market Developments
    16.6.6 Key Strategies
    16.7 Boston Scientific Corporation
    16.7.1 Overview
    16.7.2 Offerings
    16.7.3 Key Financials
    16.7.4 Business Segment & Geographic Overview
    16.7.5 Key Market Developments
    16.7.6 Key Strategies 
    16.8 LivaNova Plc
    16.8.1 Overview
    16.8.2 Offerings
    16.8.3 Key Financials
    16.8.4 Business Segment & Geographic Overview
    16.8.5 Key Market Developments
    16.8.6 Key Strategies 
    16.9 ElectroCore LLC
    16.9.1 Overview
    16.9.2 Offerings
    16.9.3 Key Financials
    16.9.4 Business Segment & Geographic Overview
    16.9.5 Key Market Developments
    16.9.6 Key Strategies 
    16.10 NeuroPace Inc.
    16.10.1 Overview
    16.10.2 Offerings
    16.10.3 Key Financials
    16.10.4 Business Segment & Geographic Overview
    16.10.5 Key Market Developments
    16.10.6 Key Strategies